Patent & IP news for February 11, 2013

District of Delaware Invalidates Entecavir Patent as Obvious from www.orangebookblog.com

Bristol-Myers Squibb v. Teva Pharms., No. 10-805-CJB (D. Del.) by Aaron F. Barkoff Today, Judge Burke of the District of Delaware issued a 171-page opinion (part 1; part 2) holding that claim 8 of U ...

Share via E–mail | Twitter | Facebook

South Korea Inks Copyright Protection Deal With Vietnam from www.ip-watch.org

Manila, Philippines – The Republic of Korea, or South Korea, has signed an agreement with Vietnam for stronger collaboration in the area of copyright protection. This reflects South Korea's continuing and more aggressive campaign to ...

Share via E–mail | Twitter | Facebook

What I want to hear in the State of the Union - 2013 edition from www.athenaalliance.org

According to press reports, the President's State of the Union address on Tuesday will focus on the economy and the middle class. Pundits are noting the difference with Obama's Inaugural Address, but I ...

Share via E–mail | Twitter | Facebook

All-time Best Corporate Character Mascots from www.ipwatchdog.com

Recently Inc.com published an article titled The Art and Science of Corporate Icons, which discusses Skeeter the squirrel, who is apparently the only squirrel in the world allergic to nuts. Skeeter is also the ...

Share via E–mail | Twitter | Facebook

No Federal Cause of Action against Inventor’s Attempt to Derrogate Patent in Violation of Assignor Estoppel Doctrine from www.patentlyo.com

By Dennis Crouch Semiconductor Energy Labs v. Nagata (Fed. Cir. 2013) SEL is a Japanese "research company" owned by mega-inventor Shunpei Yamazaki who is named as inventor of more than 750 U.S. patents. Dr ...

Share via E–mail | Twitter | Facebook

Report Proposes Solutions To Address Non-Communicable Diseases from www.ip-watch.org

An industry-backed group of experts has issued a report identifying significant obstacles to addressing non-communicable diseases (NCDs) and proposing solutions to reduce premature deaths caused by NCDs. Related Articles:

• New IFPMA-Backed Report On R&D ...

Share via E–mail | Twitter | Facebook

USPTO, NSF and NBC Launch “Science of Innovation” Series from www.ipwatchdog.com

United States Patent and Trademark Office (USPTO), the National Science Foundation (NSF), and NBC Learn, the educational arm of NBC News, today launched an 11-part “Science of Innovation” series to coincide with the 165th birthday ...

Share via E–mail | Twitter | Facebook

Peter DiCola: A Study of Income from Copyright Protected Sources from www.iposgoode.ca

Peter DiCola, assistant professor at Northwestern University School of law recently released a study on the income earned by musicians from copyright protected sources.  The goal of the study, entitled Money from Music: Survey Evidence ...

Share via E–mail | Twitter | Facebook

Privateering: Patent Holding Companies Unleash Patent Portfolios from www.ipwatchdog.com

There is a tremendous amount of unrealized (“un-monetized”) value in the patent portfolios of many large companies. Yet, for one reason or another, such companies have chosen over the years not enforce their patents in ...

Share via E–mail | Twitter | Facebook

ALJ Pender Issues Public Version of Initial Determination in Certain Kinesiotherapy Devices (337-TA-823) from www.itcblog.com

On February 8, 2013, ALJ Thomas B. Pender issued the public version (dated January 8, 2013) of the Initial Determination (“ID”) finding no violation of Section 337 in Certain Kinesiotherapy Devices and Components Thereof (Inv ...

Share via E–mail | Twitter | Facebook

Tela Files New 337 Complaint Regarding Certain Integrated Circuit Devices from www.itcblog.com

On February 8, 2013, Tela Innovations, Inc. of Los Gatos, California (“Tela”) filed a complaint requesting that the ITC commence an investigation pursuant to Section 337. The complaint alleges that the following entities (collectively, the ...

Share via E–mail | Twitter | Facebook

Upcoming Oral Arguments in Myriad from www.patentlyo.com

Association for Molecular Pathology v. Myriad Genetics, Inc. (SCOTUS 2013) The Supreme Court has now set oral arguments for April 15, 2013. The questions on appeal are posed as follows: Many patients seek genetic testing ...

Share via E–mail | Twitter | Facebook